2026-2034年全球哺乳動物細胞發酵技術市場規模、佔有率、趨勢和成長分析報告

預計哺乳動物細胞發酵技術市場將從 2025 年的 572.9 億美元成長到 2034 年的 1,273.3 億美元，2026 年至 2034 年的複合年成長率為 9.28%。

由於生物製藥和生物製藥的需求持續成長，哺乳動物細胞發酵技術市場預計將迎來顯著成長。哺乳動物細胞發酵是治療性蛋白質、單株抗體和疫苗生產的關鍵工藝，使其成為生物製藥產業不可或缺的技術。慢性病發病率的上升以及對個人化醫療日益成長的關注，正在推動對哺乳動物細胞發酵技術的投資，並進一步擴大市場規模。

技術創新在塑造哺乳動物細胞發酵技術市場的未來方面發揮著至關重要的作用。生物反應器設計、細胞培養基和製程最佳化的創新正在提高哺乳動物細胞發酵製程的效率和擴充性。此外，自動化和數據分析的整合正在改善發酵過程的監控和控制，從而提高產量並縮短生產時間。隨著製造商不斷創新和開發新的解決方案，預計哺乳動物細胞發酵技術將在各種生物製藥應用領域中得到更廣泛的應用。

此外，對監管合規和品質保證日益重視也影響著哺乳動物細胞發酵技術市場的成長軌跡。隨著監管機構對生物製藥生產實施更嚴格的指導方針，對符合這些標準的發酵技術的需求預計將會增加。這一趨勢正在推動技術提供商和生物製藥公司之間的合作，以開發確保合規並提高產品品質的整合解決方案。隨著市場的不斷發展，技術、監管合規和品管的整合將是成功的關鍵。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球哺乳動物細胞發酵技術市場：按類型分類

• 市場分析、洞察與預測
• 中國倉鼠卵巢（CHO）細胞發酵
• 人類胎腎（HEK）細胞發酵

第5章：全球哺乳動物細胞發酵技術市場：以倉鼠腎臟（BHK）細胞發酵為例

• 市場分析、洞察與預測
• 小鼠骨髓瘤細胞發酵
• 其他

第6章 全球哺乳動物細胞發酵技術市場：依應用領域分類

• 市場分析、洞察與預測
• 單株抗體
• 重組蛋白
• 疫苗
• 荷爾蒙
• 酵素
• 其他

第7章 全球哺乳動物細胞發酵技術市場：依最終用途分類

• 市場分析、洞察與預測
• 生物製藥公司
• 合約生產組織/合約開發組織
• 學術研究機構

第8章 全球哺乳動物細胞發酵技術市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Danaher
  • Lonza
  • F. Hoffmann-La Roche Ltd
  • Sartorius AG
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen
  • Gilead Sciences
  • Moderna Inc
  • Regeneron Pharmaceuticals

The Mammalian Cell Fermentation Technology Market size is expected to reach USD 127.33 Billion in 2034 from USD 57.29 Billion (2025) growing at a CAGR of 9.28% during 2026-2034.

The Mammalian Cell Fermentation Technology Market is poised for significant growth as the demand for biopharmaceuticals and biologics continues to rise. Mammalian cell fermentation is a critical process in the production of therapeutic proteins, monoclonal antibodies, and vaccines, making it essential for the biopharmaceutical industry. The increasing prevalence of chronic diseases and the growing focus on personalized medicine are driving investments in mammalian cell fermentation technologies, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the mammalian cell fermentation technology market. Innovations in bioreactor design, cell culture media, and process optimization are enhancing the efficiency and scalability of mammalian cell fermentation processes. Additionally, the integration of automation and data analytics is improving the monitoring and control of fermentation processes, enabling higher yields and reduced production times. As manufacturers continue to innovate and develop new solutions, the mammalian cell fermentation technology market is likely to see increased adoption across various biopharmaceutical applications.

Moreover, the growing emphasis on regulatory compliance and quality assurance is influencing the mammalian cell fermentation technology market's growth trajectory. As regulatory agencies implement stricter guidelines for biopharmaceutical production, the demand for fermentation technologies that meet these standards is expected to rise. This trend is driving collaboration between technology providers and biopharmaceutical companies to develop integrated solutions that ensure compliance and enhance product quality. As the market continues to evolve, the integration of technology, regulatory compliance, and quality management will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Chinese Hamster Ovary (CHO) Cell Fermentation
• Human Embryonic Kidney (HEK) Cell Fermentation
• Baby Hamster Kidney (BHK) Cell Fermentation
• Murine Myeloma Cell Fermentation
• Others

By Application

• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Hormones
• Enzymes
• Others

By End-Use

• Biopharmaceutical Companies
• CMOs & CDMOs
• Academic & Research Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Danaher, Lonza, F HoffmannLa Roche Ltd, Sartorius AG, AstraZeneca, BristolMyers Squibb, Amgen, Gilead Sciences, Moderna Inc, Regeneron Pharmaceuticals

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Chinese Hamster Ovary (CHO) Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Human Embryonic Kidney (HEK) Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY BABY HAMSTER KIDNEY (BHK) CELL FERMENTATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Baby Hamster Kidney (bhk) Cell Fermentation
• 5.2. Murine Myeloma Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hormones Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. CMOs & CDMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Baby Hamster Kidney (bhk) Cell Fermentation
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Baby Hamster Kidney (bhk) Cell Fermentation
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Baby Hamster Kidney (bhk) Cell Fermentation
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Baby Hamster Kidney (bhk) Cell Fermentation
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Baby Hamster Kidney (bhk) Cell Fermentation
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Merck KGaA
  • 10.2.3 Danaher
  • 10.2.4 Lonza
  • 10.2.5 F. Hoffmann-La Roche Ltd
  • 10.2.6 Sartorius AG
  • 10.2.7 AstraZeneca
  • 10.2.8 Bristol-Myers Squibb
  • 10.2.9 Amgen
  • 10.2.10 Gilead Sciences
  • 10.2.11 Moderna Inc
  • 10.2.12 Regeneron Pharmaceuticals